Pfizer to halt biosimilar output in China, sell assets to WuXi Biologics

  • 📰 ChannelNewsAsia
  • ⏱ Reading Time:
  • 41 sec. here
  • 2 min. at publisher
  • 📊 Qulity Score:
  • News: 20%
  • Publisher: 66%

Pfizer Inc has decided to stop producing biosimilar products in China and sell a unit in the eastern city of Hangzhou to WuXi Biologics Inc, the U.S.

Singapore Headlines News

Singapore Latest News, Singapore Headlines

FILE PHOTO: Pfizer logo seen outside their building in Manhattan, New York City, New York, U.S., March 2, 2021. REUTERS/Carlo AllegriThe pharmaceutical industry increasingly relies for its profits on costly biologic drugs, made from living organisms that are tougher and more expensive to make than conventional medicines with chemical ingredients."The site was planned to manufacture three biosimilars for the China market," the company said in a response to Reuters.

"Pfizer commercially and technically evaluated other products for the site but none reached the level of activity for the scale of the site." Neither Pfizer nor WuXi disclosed the deal value, or the products to be made after the transaction closes, which is expected in the first half of this year. WuXi said the deal would allow it to address surging manufacturing demand for drug substances and drug products.The facilities are equipped with bioreactors and capable of filing vials and syringes, the Chinese firm said in a statement on the WeChat app.

WuXi also makes vaccine substances for a COVID-19 shot developed by AstraZeneca PLC and the University of Oxford to supply them to Brazil, but did not have immediate comment on whether the plant would turn out such substances.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 6. in SG
 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

China embassy takes swipe at 'fusty' Japan over South China SeaChina's embassy in the Philippines has blamed 'some external countries' for stoking tensions in the region, in remarks aimed at Japan after its ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Philippines, Vietnam press China over vessels massing in South China SeaPhilippine President Rodrigo Duterte expressed concern to China's ambassador about Chinese vessels massing in the South China Sea, his spokesman said, as Vietnam urged Beijing to respect its maritime sovereignty. International concern has grown in recent days over what the Philippines has described as a 'swarming and threatening presence' of more than 200 Chinese vessels that it believes were manned by maritime militia.
Source: YahooSG - 🏆 3. / 71 Read more »

Philippines' defence secretary says China intends to occupy more South China Sea areasMANILA: The Philippines' defence secretary said on Sunday (Apr 4) that China was looking to occupy more areas in the South China Sea, citing the ... 4.4.2021 The dudirty legacy 👊 Chief we knew it from the very first time CCP drew the perforated line over the sea and reclaim the first island in front of your doorstep.
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Pfizer begins Covid vaccine trial in young childrenPfizer said Thursday it had begun clinical trials for its Covid vaccine in children under the age of eleven, an early sign of the next stage of the global immunization campaign.
Source: YahooSG - 🏆 3. / 71 Read more »

Pfizer, BioNTech launch Covid-19 vaccine trial in kids under 12
Source: TODAYonline - 🏆 1. / 99 Read more »